A Clinical Study of FT1 in Patients With Short Bowel Syndrome

Summary

The goal of this clinical trial is to learn if FT1 is safe and works to treat short bowel syndrome (SBS) in adults. It will also learn about the PK/PD profile of FT1. Researchers will compare FT1 to a placebo (a look-alike substance that contains no drug) to see if FT1 is safe and effective in patients with SBS. Participants will * Receive multiple injections of FT1 or placebo according to weight. * Visit the clinic for assessment.

Timeline

Start

2026-08-30

Primary completion

2027-04-15

Completion

2027-04-15

Drugs

Indications